Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - The Lancet, 2021 - thelancet.com
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …
被引用次数：252 相关文章

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - The Lancet, 2021 - Elsevier
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …
[PDF] medisimaging.com

[PDF][PDF] Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - 2021 - medisimaging.com
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …

[引用][C] Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu… - The …, 2021 - produccioncientifica.ucm.es

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, Y Chen… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …

[引用][C] Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - The Lancet, 2021 - cir.nii.ac.jp
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a
multicentre, randomised, sham-controlled trial | CiNii Research CiNii 国立情報学研究所 学術 …

Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu… - Lancet (London …, 2021 - europepmc.org
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …
[PDF] eukon.it

[PDF][PDF] Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial

B Xu, S Tu, L Song, Z Jin, B Yu, G Fu, Y Zhou, J Wang… - 2021 - eukon.it
Background Compared with visual angiographic assessment, pressure wire-based
physiological measurement more accurately identifies flow-limiting lesions in patients with …